We are pleased to announce an important development for Trenker Laboratories. As of June 27, 2024, Trenker Laboratories has been acquired by Erudite.Health, led by the dynamic entrepreneurs, Charles and Louis Declerck. This transition marks a significant milestone in our journey and opens up new avenues for growth and innovation.
Trenker has always been a pioneer in offering high quality nutritional supplements that provide both health professionals and patients with real added value in terms of health.
A New Chapter with Erudite.Health
Today, we proudly pass the torch to Charles and Louis Declerck. Their profound scientific and financial backgrounds, combined with their entrepreneurial spirit, make them ideal stewards for Trenker’s future. Under their leadership, Trenker will continue to thrive, maintaining its core values while leveraging new expertise and resources.
Charles and Louis, through Erudite.Health, aim to enhance life quality by integrating complementary healthcare solutions. They bring a vision of sustainable growth, linking conventional medicine and health products for the benefit of healthcare professionals and patients. Trenker will play a pivotal role within Erudite.Health, furthering its mission to provide scientifically-backed, personalized healthcare.
Our Continued Involvement
I will have the pleasure of accompanying Trenker as CEO until the end of 2024, and then serve the group as an advisor and member of the Board of Directors. My commitment to Trenker remains intact and I am confident that this transition will open an era of sustainable excellence and innovation for the company.
We extend our heartfelt gratitude to all our clients, suppliers, and stakeholders for your unwavering support over the years. Together with Charles and Louis, we are excited about the future and the opportunities it holds for Trenker. Thank you for your continued trust and partnership. Warm regards,
Rodolphe Trenker
CE0